Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025
Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and…
Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and…
Sign in to your account